← Browse by Condition

Medical Condition

spinal cord injuries

Total Trials

24

Recruiting Now

24

Trial Phases

Phase 4, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for spinal cord injuries sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — spinal cord injuries Clinical Trials

How many clinical trials are currently recruiting for spinal cord injuries?

ClinicalMetric currently tracks 24 actively recruiting clinical trials for spinal cord injuries, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 24. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for spinal cord injuries?

spinal cord injuries research spans Phase 1 (2 trials), Phase 2 (3 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a spinal cord injuries clinical trial?

Eligibility criteria for spinal cord injuries trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

2

Phase 2

3

Phase 4

1

Top Sponsors

Leigh R. Hochberg, MD, PhD. 3 trials

Institut Guttmann 2 trials

James J. Peters Veterans Affairs Medical Center 1 trial

Marzieh Salehi 1 trial

Cardiff and Vale University Health Board 1 trial

Recruiting Clinical Trials

Seated Balance Using the Indego™

James J. Peters Veterans Affai...

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)

Leigh R. Hochberg, MD, PhD.

NCT06706284 Phase 4

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

High Flow Oxygen Therapy After Spinal Cord Injury

Cardiff and Vale University He...

Machine-Learning Based EEG Biomarkers for Personalized Interventions

Institut Guttmann

NCT06559618 Phase 1

Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria

Barbara Trautner

Spinal Cord Injury Neurorecovery Collaboration

University of Melbourne

Wrist Extensor MEP Up-conditioning for Individuals With Incomplete Spinal Cord Injury

Medical University of South Ca...

NCT05317832 Phase 2

Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury

Temple University

The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)

Kessler Foundation

Epidural Electrical Stimulation to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury

Ecole Polytechnique Fédérale d...

Repetitive Transcranial Magnetic Stimulation Therapy in Spinal Cord Injury Related Neuropathic Pain

Turkey (Türkiye)

Afyonkarahisar Health Sciences...

Efficacy of rTMS Treatment After Spinal Cord Injury

Oslo University Hospital

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

Leigh R. Hochberg, MD, PhD.

AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis

University of Alabama at Birmi...

Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

Spaulding Rehabilitation Hospi...

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

Leigh R. Hochberg, MD, PhD.

Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury

Loewenstein Hospital

NCT04565925 Phase 2

Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

The University of Texas Medica...

Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury

University College, London

Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea

Wayne State University

Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury

The Methodist Hospital Researc...

Development of a Novel Strategy to Analyze the Effect on Gait Using Transcutaneous Spinal Current Stimulation in Incomplete Spinal Cord Injured Patients

Institut Guttmann

NCT06596291 Phase 1, Phase 2

Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization

Related Conditions

tetraplegia (3) amyotrophic lateral sclerosis (3) neuropathic pain (2) anarthria (2) dysarthria (2) brain stem infarctions (2) locked in syndrome (2) muscular dystrophies (2) neuromodulation (2) neurogenic detrusor overactivity (2) brainstem stroke (1) als (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology